News Archive for Novartis Court Case Articles February 28, 2007. The Times of India. IPI comes clean on Mashelkar report. February 25, 2007. Daiji World. Caution over Swiss Firm Patenting Cancer-fighting Drug. February 24, 2007. Nitin Sethi for the Times of India. Mashelkar draws health activists' ire. February 24, 2007. Saubhik Chakrabarti for One World South Asia. Why Be A Pill Pauper? February 24, 2007. Amitabh Sinha for the Indian Standard. Mashelkar replies: I stand by the patent report, 100 per cent. February 23, 2007. The Business Standard. Scrap panel on patents: CPM to govt. February 23, 2007. Editorial in the Indian Express. Patent report fracas showcases a pharma question. Activists can’t have a monopoly on the answer. February 22, 2007. Manoj Mitta for the Times of India. Mashelkar takes back report after plagiarism row. February 22, 2007. Jaya Menon for the Indian Express. Plagiarised report figures in Novartis hearing. February 22, 2007. Kay Benedict for DNA-India. Experts, Left trash report by Mashelkar. February 22, 2007. Pallava Bagla for the Indian Express. 'Plagiarism' in his panel’s report, Mashelkar tells Govt to withdraw it. February 21, 2007. Zee News. Ex-Swiss President Says Novartis Case Reduces Patent Flexibilities. February 20, 2007. Kaiser News Network. Indian Court Hears Arguments In Case Against Country's Patents Act. February 20, 2007. Roger Bate for the American Enterprise Institute. Populism versus the Poor. Februry 19, 2007. KG Narendranath and Gireesh Chandra Prasad. Mashelkar prescription may get second opinion. February 16, 2007. India Business Standard. EU, US oppose Novartis' Glivec move. February 16, 2007. Ekklesia News. Desmond Tutu backs campaign to stop drug companies profiting from the poor. February 16, 2007. Amitabh Pal for the Progressive. Corporate Globalization Kills. February 15, 2007. Tove Iren S. Gerhardsen for IP-Watch. Opposition Gains Support Against Novartis Patent Lawsuit In India. February 15, 2007. Victoria Gill for Chemistry World. Novartis contests India's patent law. February 7, 2007. Mmegi (Botswana). Drug patents and their implications on ARV therapy access. February 7, 2007. Bangkok Post editorial. Generic drugs under assault. February 6, 2007. South African Broadcasting Corporation. Swiss pharmaceutical challenges India's Patent Act. February 5, 2007. Jean François Tremblay for Chemical and Engineering News. Drug patent struggles in Asia. February 4, 2007. Reghu Balakrishnan for DNA-India. Cancer drug patent woes mount for Novartis. February 1, 2007. Kaiser News Network. HIV/AIDS Advocates Protest Novartis' Case Challenge India Patent Law. January 30, 2007. Noemie Bisserbe for the Economic Times. Novartis takes on patent law in Glivec case. January 30, 2007. Keya Acharya for the Inter Press News. Anger Grows at Novartis' Bid to Hog Cancer Drug. January 29, 2007. Jeremy Clark for Reuters. Swiss drug case threatens developing world: MSF. January 29, 2007. Amelia Gentleman for the International Herald Tribune. Drugs for poor and patent rights at issue in Novartis suit in India. January 29, 2007. Al Jazeera. Novartis in Drug Patent Fight. January 29, 2007. Ellen 't Hoen (MSF) and Celine Charveriat (Oxfam). Letter to the editor of the Financial Times. What could be more of a short-term fix than the Novartis programme? January 29, 2007. Matthew Allen for SwissInfo. Novartis challenges India's patent law. January 23, 2007. Ganapati Mudur for the Birish Journal of Medicine. MSF challenges Novartis's action over Indian patent for imatinib. January 17, 2007. EurActiv.com EU urged to support India in drug-patent battle. January 15, 2007. Apoorva Mandavilli for Nature. Petition aims to maintain cheap drugs - Court case in India threatens to derail generic medicines. January 5, 2007. Lancet editorial. Undermining TRIPS: protectionism at its worst. December 21, 2006. Times of India. Novartis sues India over patent rejection. December 21, 2006. AFX News. Novartis sues Indian govt over cancer drug patent rejection. December 20, 2006. South African Press Association. Drop patent challenge, drug company urged. December 20, 2006. Seema Singh for the Red Herring. Novartis Urged to Drop India Suit. December 19, 2006. Reuters. MSF urges Novartis to drop patents case in India. October 19, 2006. Tove Iren S. Gerhardsen for Intellectual Property Watch. Novartis Persists With Challenge To Indian Patent Law Despite Adversity.
